PGL 0.00% 85.0¢ prospa group limited.

Nexavar looks on track to steal any market share they would have...

  1. 498 Posts.
    Nexavar looks on track to steal any market share they would have had if the drug showed statistical efficacy. Be prepared for a brutal fall below $1.

    Nexavar is 18 months ahead of PI-88, now.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.